PR Newswire – Start of Day

Globe NewswirePhase III prevention trial showed subcutaneous administration of investigational antibody cocktail casirivimab and imdevimab reduced risk of symptomatic COVID-19...

Page 40 of 41 1 39 40 41

Other Newzz